Nova Leap Health Corp.
NLH.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 526.31% | -191.59% | -52.02% | 149.55% | -350.97% |
| Total Depreciation and Amortization | 1.50% | 5.26% | -7.58% | -20.77% | -7.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -358.32% | 947.15% | 87.03% | -121.80% | 869.85% |
| Change in Net Operating Assets | 206.59% | -37.99% | 65.35% | 133.55% | -93.24% |
| Cash from Operations | 17.89% | -25.90% | 3.58% | -32.57% | -13.33% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -156.10% | -1.44% | 38.73% | 80.62% | -86.56% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 2.88% |
| Cash from Financing | 1,254.47% | -1.44% | 38.73% | 80.88% | -84.37% |
| Foreign Exchange rate Adjustments | -15,800.00% | -92.86% | 130.43% | -185.19% | 280.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -78.63% | 302.47% | -78.11% | 204.72% | -197.03% |